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1116-18 Does Cardiac Multislice Computed Tomography Change 
the Indication for Invasive Angiography in Symptomatic 
Patients With Suspected Coronary Artery Disease?
Ralph Haberl, Janine Tittus, Eike Boehme, Andreas Czernik, Barbara Richartz, Jürgen 
Buck, Peter Steinbigler, Klinik München-Pasing, 81241Munich, Germany
Background: Noninvasive coronary angiography with multislice spiral CT (CT-A) pro-
duces impressive images, however, it is unclear, whether this new technique adds addi-
tional information that may change the indication for invasive coronary angiography (Inv-
A).
Methods: We therefore studied 118 consecutive symptomatic patients with suspected
CAD and an indication for Inv-A according to standard criteria (angina and signs of
ischemia in bicycle stress test, stress echocardiography and/or scintigraphy). Patients
with known CAD or acute coronary syndrome were excluded. In all patients both Inv-A
and CT-A (Philips MX8000 multislice spiral CT, scan time 250ms, slice width 1.1mm,
120cc of contrast medium, 4cc/sec, retrospective gating) were directly compared by two
independent investigators using the AHA 15-segment model (a total of 1.534 segments
were studied). Each patient received metoprolol 100mg pos., patients with a calcium
score (CS)>1000 were excluded (12 patients). The results are presented unpolished
without exclusion of segments with poor image quality. Significant stenosis (SS) was
defined as >50% lumen obstruction.
Results: 61 patients (52%) had SS in Inv-A. CT-A correctly identified 52/61 patients with
SS (sensitivity 85%) and all of the patients who ultimately underwent intervention (49
patients, sensitivity 100%). In 41 patients (35%), both Inv-A as well as CT-A correctly
excluded SS. CT-A false positively diagnosed SS in 16/57 cases with no or only insignifi-
cant stenoses in Inv-A (specificity 72%). The major reason for impaired sensitivity were
motion artifacts and severely calcified plaques masking SS. Specificity was impaired
mainly by misclassification of nonobstructive plaques in CT-A as SS. Calcium scoring
alone was less reliable: of 20 patients with CS=0, five had SS in CT-A and Inv-A, whereas
25/57 patients (43%) without SS revealed an age related elevated CS.
Conclusion: CT-A with multislice spiral CT, but not calcium scoring alone, is a highly
valuable additional test in symptomatic patients with suspected CAD to reduce the num-
ber of catheter procedures by up to 35% with minimal risk for the patient.
Noon
1116-19 Self-Gating in Pediatric Cardiac Magnetic Resonance 
Imaging
Tiffanie R. Johnson, Orlando Simonetti, Andrew Larson, Mark A. Fogel, Children's 
Hospital of Philadelphia, Philadelphia, PA, Siemens Medical Solutions, Malvern, PA
Background: Cardiac magnetic resonance (MR) uses the electrocardiogram (ECG) to
synchronize image data acquisition. In 5% of cases, a reliable ECG cannot be obtained.
The ability to perform cardiac MR without ECG would make MR more robust.
Methods: A new method of using motion-induced changes in the image data to retro-
spectively synchronize the data to the cardiac cycle has been developed. To determine if
this “self-gating” method of cine MR can be substituted for the ECG, we performed car-
diac MR with this new sequence on 20 pts (1.2-20.2 yrs) with congenital heart disease
(CHD). Diagnoses included Fontan operation, pulmonary stenosis/regurgitation, tetralogy
of Fallot, pulmonary atresia with intact ventricular septum, and Rastelli repair. Shortening
fraction, fractional area change, and blood vessel diameter in both ECG and self-gated
techniques were measured. The paired t-test and regression analysis were used.
Results: All self-gate sequences were successful. For all linear and area measurements
there was no significant difference between the ECG and self-gated images (n=218,
P=0.507), and correlation was excellent (r=0.995). No statistically significant difference in
measurements performed between the ECG and self-gated images could be identified
(Power = 99%). (Figures)
Conclusion: Cardiac MR in CHD can be successfully performed without the use of the
ECG. The new self-gating technique provides accurate information, makes the modality
more robust, and is a technical advance in the field.
Noon
1116-20 Magnetic Resonance Imaging Predictors of the 
Hemodynamic Severity of Aortic Coarctation
James Nielsen, Andrew J. Powell, Kimberlee Gauvreau, Edward Marcus, Tal Geva, 
Children's Hospital, Boston, MA
Background: MRI is increasingly utilized for anatomic assessment of aortic coarctation
(Coarc) but its ability to predict the hemodynamic severity of the obstructive lesion has
not been studied in detail. The goal of this study was to identify independent MRI vari-
ables predictive of hemodynamically significant Coarc as determined by cardiac catheter-
ization (Cath).
Methods: Patients who fulfilled the following criteria were included: 1) MRI assessment
of native or recurrent Coarc with contrast-enhanced 3D MRA of the aorta and phase
velocity encoded cine MRI flow measurements in the ascending and proximal descend-
ing aorta (DAo); 2) Cath with hemodynamic evaluation of Coarc. Patients with cardiac
index <2.2 L/min/m2 by Cath were excluded. Patients were divided into 2 groups based
on peak Coarc gradient by Cath: 1) <20 mm Hg (n= 12); 2) >20 mm Hg (n=19). Logistic
regression analysis was used to calculate odds ratios (OR) and areas under the receiver-
operator characteristic (ROC) curve to determine MRI predictors of Coarc gradient >20
mm Hg and multivariate logistic regression was used to develop a rule for predicting the
probability of Coarc gradient >20 mm Hg.
Results: By logistic regression analysis, the following variables predicted Coarc gradient
>20 mm Hg: 1) smallest aortic cross-sectional area indexed to body surface area (AoC-
SAi) (OR 1.71 for 10 mm2/m2 decrease, p=0.005, ROC=0.87); 2) heart rate (HR)-cor-
rected DAo flow duration (OR 1.27 for 0.01 sec0.5 increase, p=0.012, ROC=0.86); 3) HR-
corrected DAo flow fall time (OR 1.32 for 0.01 sec0.5 increase, p=0.009, ROC=0.85); 4)
HR-corrected DAo mean flow deceleration (MDec) (OR 1.68 for 100 cc/sec1.5 increase,
p=0.018, ROC=0.84). By multivariate analysis, AoCSAi (OR 1.62, p=0.02) and DAo HR-
corrected MDec (OR 1.66, p=0.005) were independent predictors of Cath gradient >20
mm Hg. The combination of AoCSAi and DAo HR-corrected MDec predicted Coarc
severity group with 95% sensitivity, 82% specificity, and ROC area of 0.94.
Conclusion: The combination of anatomic and flow data obtained by MRI provides a
sensitive and specific test for predicting of Cath gradient >20 mm Hg. These findings
should be prospectively validated.
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1116-21 Comparison Between Myocardial Contrast 
Echocardiography and Contrast Enhanced Magnetic 
Resonance Imaging in Prediction of the Myocardial 
Viability After Direct Percutaneous Transluminal 
Coronary Angioplasty in Acute Myocardial infarction
Haesun Seo, Jae Youn Moon, Young-Guk Ko, Seok-Min Kang, Jong-Won Ha, Se-Joong 
Rim, Yangsoo Jang, Wonheum Shim, Seung-Yun Cho, Kyu Ok Choe, Namsik Chung, 
Byoung Wook Choi, Yonsei University Cardiovascular Center, Seoul, South Korea
Background: Both myocardial contrast echocardiography (MCE) and contrast enhanced
magnetic resonance imaging (MRI) can identify myocardial perfusion following acute
myocardial infarction (AMI). We sought to compare the relative accuracy of these tech-
niques in the assessment of myocardial perfusion and prediction of myocardial viability.
Method: Twenty two patients (age : 59 ± 10 years, 18 men) with AMI who were success-
fully revascularized by direct PTCA underwent real time MCE and MRI within 7 days after
revascularization. Preserved myocardial perfusion by MCE was defined as full enhance-
ment of myocardium with microbubbles at the 10th endsystolic cardiac cycle after high
mechanical bubble destruction. Delayed hyperenhancement of less than 50% transmural
thickness on MRI was considered as preserved myocardial perfusion. The LV wall motion
was assessed by echocardiography 12 weeks later. Results: Total 352 myocardial seg-
ments(16 segments per patient) were analyzed. Sensitivity and specificity of preserved
myocardial perfusion by MCE in the prediction of myocardial viability was 86.3% and
59.3%respectively. Delayed hyperenhancement of less than 50% transmural thickness
on MRI predicted myocardial viability with sensitivity of 82.4% and specificity of 90.7%
respectively. Concordance between MCE and MRI for the identification of myocardial
perfusion was 78.3% (kappa = 0.42). Conclusions: There was fair concordance
between MCE and MRI for the assessment of myocardial perfusion after AMI. Both tech-
niques showed comparable sensitivity for prediction of myocardial viability, however, MRI
demonstrated better specificity.
Noon
1116-22 Development of a Transgenic Mouse Model for Imaging 
of Cellular Differentiation Into Cardiomyocyte
Jin Chul Paeng, Dong Soo Lee, Joo Hyun Kang, June-Key Chung, Myung Chul Lee, 
Seoul National University College of Medicine, Seoul, South Korea
Background: With increasing therapeutic application of stem cells to diverse heart dis-
ease, in vivo imaging method of cellular differentiation is required. We developed a trans-
genic mouse model to image the differentiation into cardiomyocyte.
Methods: Alpha-myosin heavy chain (α-MHC) promoter is a specific gene expression
regulator for differentiated cardiomyocyte, and sodium/iodide symporter (NIS) is one of
promising reporter genes, which takes up radioactive iodine. A DNA construct comprising
human NIS gene driven by a murine α-MHC promoter was synthesized. The DNA con-
struct was tested in rat myoblast cell lines for the uptake of iodine. Linearized vectors of
the construct were microinjected into fertilized eggs of FVB mouse strain and positive
founders were identified by PCR typing. To test the adequacy of the transgenic mouse
model, in vivo image was acquired using 131I and gamma camera. Also the uptake was
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assessed after administration of KClO4, an inhibitor of NIS.
Results: The myocardium of transgenic mouse showed intense uptake of 131I (7.1-fold of
control), which was much higher than that of the skeletal muscles, thyroid, and stomach
(figure). Also, the myocardial uptake of 131I was completely blocked by administration of
KClO4.
Conclusion: We developed a transgenic mouse model to image the differentiated cardi-
omyocyte using α-MHC promoter and NIS. The transgenic mouse model is expected to
be effective for tracking cellular differentiation into cardiomyocyte by in vivo imaging
method.
Noon
1116-23 Noninvasive Detection of Angiogenesis With a 
Technetium-99m Labeled Peptide Targeted at αvβ3 
Integrin Following Hindlimb Ischemia
Jing Hua, Brian N. Bourke, James Song, Conroy Chow, Mehran M. Sadeghi, Patti 
Cavaliere, Xiaoyue Hu, Neda Jahanshad, Lawrence W. Dobrucki, Niels VanRoyen, Marivi 
Mendizabal, Ivo Buschmann, Albert J. Sinusas, Yale University, New Haven, CT
Background: The αvβ3 integrin is over-expressed in angiogenic vessels, and represents
a potential target for non-invasive imaging of angiogenesis.
Methods: We evaluated a technetium-99m labeled peptide, NC100692 (NC), targeted at
αvβ3 integrin for imaging in an established murine model of angiogenesis induced by
hindlimb ischemia. Mice (n=23) underwent a surgical right femoral artery occlusion (OC)
and contralateral sham operation. NC (1.35±0.15 mCi, i.v.) was injected (INJ) in control
mice or at different times after OC (3d, 7d, 2wk and 8wk), and in vivo pinhole planar
imaging performed at 75 min after INJ. 90 min after NC INJ, tissue from hindlimb (HL)
proximal (P) and distal (D) to OC was excised for gamma well counting (GWC), and for
quantitative immunohistochemical staining of lectin D to OC. HL muscles were divided
into 3 groups for GWC; 1) P upper (U) HL, 2) DUHL, and 3) lower (L) HL. Regional activ-
ity on ischemic (I) HL was normalized to non-ischemic (NI). ROIs were drawn on in vivo
images in region distal to OC, and I/NI ratios calculated.
Results: Relative NC activity by GWC was significantly increased in DUHL and LHL at
7d after OC. On in vivo pinhole images increased focal NC activity was seen distal to OC
at 3d and 7d. Lectin staining confirmed increased angiogenesis in LHL at 3d and 7d post
OC.
Conclusions: NC selectively localized in regions of increased angiogenesis, and was
detectable by non-invasive imaging. NC could potentially be used for non-invasive serial
“hot spot” imaging of angiogenesis.
Noon
1116-24 Assessment of Myocardial Perfusion and Metabolism in 
Normal and Diabetic Rats by MicroPET Imaging
Pilar Herrero, Joonyoung Kim, Terry Sharp, Carmen Dence, Jason S. Lewis, Robert John 
Gropler, Michael J. Welch, Washington University School of Medicine, St. Louis, MO
Background: Small animal positron emission tomography (microPET) imaging has the
potential to accurately phenotype various rodent models of cardiovascular disease. We
are currently developing and validating techniques to measure myocardial perfusion and
metabolism in rodents that utilize radiotracers and compartmental kinetic models vali-
dated in animal models and applied to humans. We investigated whether differences in
cardiac metabolism could be detected with these techniques.
Methods: Zucker diabetic rats (D) (n=5) and lean controls (L) (n=5) (age:100 ± 27 days)
were studied under fasting conditions in one imaging session. The following measure-
ments were obtained; myocardial blood flow (MBF, mL/g/min) and myocardial oxygen
consumption (MVO2, umol/g/min) with 11C-acetate; myocardial glucose uptake
(MGUp,mL/g/min) and utilization (MGU, nmol/g/min) with 11C-glucose; and fatty acid
uptake (MFAUp mL/g/min), utilization and oxidation (MFAU, MFAO both in nmol/g/min)
with 11C-palmitate.
Results: Heart rate, MBF and MVO2 were not different between L and D. When com-
pared to L, D had higher plasma glucose (16.8 ±3.3 vs 31.6 ±1.8 mmol/L, p<.0001), free
fatty acid (894±519 vs 1665±510 nmol/mL, p<.05) and insulin levels (27±2 vs 61±9 mU/
L, p<.001). Despite higher plasma glucose and insulin levels observed in D, MGUp was
comparable between L and D (0.060±0.034 vs 0.065±0.042); however, due to higher
plasma glucose levels, MGU (MGUp x plasma glucose) tended to be higher in D
(1125±721 vs 2506±1271 p=.1). In contrast, when compared to L, MFAUp (0.38±0.11 vs
0.51±0.04, p<.05), MFAU (306± 126 vs 843±24,p<0.01) and MFAO (230±83 vs 503±205,
p<.05) were higher in D.
Conclusion: The results of this study are consistent with the well-known metabolic
changes that take place in the diabetic heart such as its reliance on fats as source of
energy as well as the observation that derangement of fatty acid metabolism precedes
that of glucose metabolism. This study demonstrates the feasibility of using microPET
imaging to phenotype myocardial metabolism in rodent models of cardiac diseases to
identify biologically relevant models to human disease.
Noon
1116-25 Percutaneous Edge-to-Edge Repair for Mitral 
Regurgitation Guided by Transesophageal and 
Transthoracic Echocardiography
L. Leonardo Rodriguez, Harry Acquatella, Susan Wiegers, Frank Silvestry, Alan 
Zunamon, John Merlino, Randy Martin, Kimberly Krabil, Elyse Foster, Ted Feldman, Jan 
Komtebedde, William J. Stewart, Cleveland Clinic Foundation, Cleveland, OH, Evanston 
Northwestern Healthcare, Evanston, IL
Background: Mitral valve repair is an increasingly attractive alternative to valve replace-
ment, but still requires thoracotomy, cardio-pulmonary bypass, and intraoperative
echocardiographic monitoring. Successful valve repairs using the edge-to-edge surgical
technique (Alfieri) have been reported. This paper presents the initial experience with
echocardiography in performing the percutaneous endovascular repair.
Methods: The endovascular Mitral Repair System (EvalveTM Redwood City, CA) uses a
steerable guide catheter to position a two-armed, V-shaped device, to approximate the
leaflet tissue near the midline of the valve. The delivery of Evalve has 5 essential steps
that require echo guidance: 1-transseptal crossing, 2-alignment of the delivery system
perfectly perpendicular to the mitral valve plane and in the center of the coaptation line 3-
alignment of the approximation implant device with the open arms perpendicular to the
coaptation line, 4- closing of the arms and approximation of the tips of the mitral valve
and 5- release of the implant device.
Results: We used a combination of transesophageal echo (TEE) and transthoracic echo
(TTE) to guide the entire procedure in 5 cases, the first performed in humans. TEE was
instrumental during steps 1, 2, 4 and 5 and TTE was helpful in step 2 and essential in
step 3. At the end of the procedure it was possible to image the 'figure 8" diastolic shape
of the double mitral valve orifice. Echo also allowed monitoring of the degree of mitral
regurgitation (MR) and transmitral gradients before and immediately after the procedure.
MR was significantly reduced in all 5 cases.
Conclusions: 1) Echocardiography, using a combination of surface and transthoracic
echo, is an essential tool for guiding the Evalve endovascular repair. 2) Endovascular
mitral valve repair appears feasible in human with severe mitral regurgitation.
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1116-26 Early Experience With Percutaneous Aortic Valve 
Implantation in Patients With Severe Nonoperable 
Aortic Stenosis
Hélène Eltchaninoff, Christophe Tron, Fabrice Bauer, Carla Agatiello, Laurent Sebagh, 
Danielle Nusimovici, Alain Cribier, Charles Nicolle Hospital, Rouen, France, 
Percutaneous Valve Technologies, Fort Lee, NJ
Backgrounds. To offer a therapeutic option to end-stage non-operable patients (Pts)
with calcific aortic stenosis (AS), we developed a percutaneous heart valve (PHV) made
of three-leaflets equine pericardium mounted in a stainless steel balloon expandable
stent.
Methods. The PHV is crimped on a 22 mm diameter-balloon catheter advanced over a
0.035 extra-stiff guidewire through a 24 Fr introducer, and delivered by balloon inflation.
This PHV was extensively tested in-vitro and in animals before being implanted in 6 Pts
(5 male; 75 + 12 yrs. Results. All Pts had severe calcific AS (0.5 + 0.1 cm²), were in
NYHA class IV and were declined for surgery due to cardiac (cardiogenic shock in two,
low ejection fraction, previous bypass surgery, porcelain aorta) and/or extracardiac rea-
sons (subacute leg ischemia; previous or evolving cancer; renal failure; stroke; age > 90
yrs). Under local anesthesia and mild sedation, the antegrade trans-septal route was
used for PHV implantation. After pre-dilatation of the native valve, PHV was successfully
deployed at mid-native aortic valve in all except one (immediate migration of PHV in the
ascending aorta leading to death in a Pt with cardiogenic shock). Autopsy revealed an
arrachement of the leaflet related to pre-dilatation. Valvular function was dramatically
improved with an increase in valve area to 1.7 + .03 cm2. Supra-aortic angiogram
showed patent coronary ostia, and mild (3 Pts) or severe (2 Pts) paravalvular aortic
regurgitation. PHV implantation led to early hemodynamic and clinical improvements. At
one week, EF was increased from 24+9 to 41+12%. Valvular function was unchanged
during follow-up on sequential echographic assessment. Three Pts died of non cardiac
cause: complication of mid-thigh amputation at 4 mths, acute abdominal syndrome at 3
weeks, hemorrhage from rectal carcinoma at 2 weeks. The two last Pts are alive.
Conclusions. This early experience confirmed that PHV implantation is feasible, leading
to dramatic valvular function improvement. Prospective studies are ongoing in our center
(I-REVIVE) and in the US and will further determine the place of this promising new ther-
apeutic alternative in non operable patients with calcific AS.
* p<0.05 vs control
NC Activity  (I/NI) Controln = 5
3 days
n = 5
7 days
n = 4
2 wks
n = 4
8 wks
n = 5
GWC PUHL 1.03±0.07 1.06±0.12 0.95±0.30 1.10±0.44 0.97±0.06
GWC DUHL 0.91±0.07 1.07±0.25 1.27±0.17* 1.19±0.38 1.04±0.13
GWC LHL 0.95±0.04 2.06±1.22 3.58±0.21* 1.47±0.57 1.10±0.18
Image LHL 0.82±0.1 1.13±0.2* 1.4±0.15* 1.18±0.25 0.9±0.15
